Nachrichten zur Helius Medical Technologies Inc. Aktie

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused…

Helius Medical Technologies reports compliance with Nasdaq equity requirements…

NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”),…

NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference…

NEWTOWN, Pa., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…

…

Company to host call at 4:30pm today Company to host call at 4:30pm today…

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple…

…

Helius Medical Technologies A öffnet am 13.05.2024 die Bücher zum am 31.03.2024 abgelaufenen Quartal.1 Analyst schätzt, dass Helius Medical …

NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”),…

…

NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…

Earnings call: Helius Medical Technologies outlines reimbursement strategy…

…

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius…